Pierre Blanchard, Editor in Chief of Radiotherapy and Oncology, aka Green Journal, Radiation Oncologist at Gustave Roussy, shared a post on X:
“No QoL difference with IMPT vs IMRT in oropharyngeal cancer in the TORPEdO trial.
How to explain the differences with Steven J. Frank US trial? Planning?
Crossover in the US trial? Real absence of difference?”
Other articles featuring Pierre Blanchard on OncoDaily.
